Healthcare Data & Diagnostic Platform Research — Architecture, Governance, Clinical AI

Problem

Healthcare data is distributed across laboratories, clinics, public systems, private providers, patient devices, questionnaires, and medical documentation. The data differs in quality, structure, accessibility, clinical relevance, and legal status.

Building a useful healthcare platform requires more than collecting results and adding an AI interface. The system must establish which data can be accessed, how it can be combined, what it may be used for, and who is responsible for interpreting the output.

What I investigated

The research covered how a platform could combine laboratory and examination results, patient-provided information, medical history, longitudinal observations, data from public and private healthcare systems, clinical recommendations, follow-up actions, and AI-assisted interpretation.

I analysed the Polish healthcare data environment, including the national P1 e-health ecosystem, its role in exchanging prescriptions, referrals, and medical-event information, and the practical constraints around integrating public data into a commercial healthcare product.

I also investigated potential architectures for using medical data in patient-facing applications, clinician support, statistical analysis, predictive modelling, retrieval-augmented generation, model training, and local and externally hosted language models.

Data architecture

The central architectural question was how to create a longitudinal patient view without collapsing all information into one unrestricted data store.

A viable design distinguishes between:

identifiable clinical data,
pseudonymised analytical data,
anonymised research datasets,
operational application data,
model inputs and outputs,
patient consent and legal basis,
data imported from external healthcare systems.

Each category may require different access policies, retention rules, hosting locations, and permitted uses. The architecture must also preserve provenance: where a result came from, when it was collected, which version is current, and whether it was supplied by a patient, laboratory, clinician, or external system.

AI processing boundaries

Deployment choices constrain what data can safely be processed. The options examined included local model deployment, infrastructure hosted in Poland, infrastructure hosted elsewhere in the EU, managed international cloud and model providers, and hybrid architectures separating sensitive data from model-facing context.

The appropriate approach depends on the purpose of processing, the identifiability of the data, contractual controls, transfer mechanisms, security architecture, and whether the output influences clinical decisions. The realistic outcome is several controlled processing paths with different data-access and validation requirements — not one universal AI pipeline.

Product and clinical workflow

The research also examined how medical data could support an ongoing service rather than a one-time test package: selecting examinations based on patient context, building a longitudinal record, identifying clinically meaningful changes, distinguishing signal from normal variation, routing selected findings for clinician review, producing understandable follow-up actions, and avoiding claims unsupported by available evidence.

A useful platform must connect data collection, interpretation, communication, and follow-up into one operational workflow.

Key challenge

The product, data architecture, clinical process, and regulatory model are interdependent. A feature that is simple from a user-interface perspective may require new consent, additional clinical validation, tighter hosting controls, or a different classification of the software. Data that is technically available may not be appropriate for model training or automated interpretation.

Impact

The research produced a clearer map of feasible product and architecture options: which data flows could be implemented directly, which require stronger safeguards, and which depend on consent, clinical governance, or further regulatory analysis. It established a basis for separating early product experimentation from the architecture required for a production medical platform.

What it demonstrates

Healthcare AI is fundamentally a data-governance and systems-design problem. Model performance matters, but it is only one layer. The platform must maintain data lineage, purpose limitation, access control, clinical accountability, validation, and an auditable connection between source data and resulting actions.

Concepts: Healthcare data · Medical data architecture · Diagnostic workflows · P1 e-health · Longitudinal records · Data governance · Clinical AI · Model deployment · Data provenance

Navigating healthcare data and AI regulation? See how I engage or get in touch.